Pharmhouse Corp (PHSE) — Financial Flexibility Index

Latest as of March 2026: -0.07x

Pharmhouse Corp (PHSE) has a Financial Flexibility Index of -0.07x as of March 2026. Free cash flow of $-571.32K (operating CF $-574.03K minus capex $2.70K) represents 0% of total liabilities ($8.23 Million). Check PHSE cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Financial Flexibility Index

-0.07x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-571.32K
Operating CF − Capex

Total Liabilities

$8.23 Million
USD

Capital Expenditures

$2.70K
USD

Pharmhouse Corp Financial Flexibility Index (1996–2025)

Historical Financial Flexibility Index trend for Pharmhouse Corp across 9 annual periods. See PHSE working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Pharmhouse Corp (1996–2025)

Year-by-year free cash flow to debt coverage for Pharmhouse Corp. For the full company profile including market capitalisation, see market value of Pharmhouse Corp.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.31x $-2.49 Million $-2.49 Million $8.05 Million ▲ +13.5%
2024 -0.36x $-614.74K $-614.75K $1.72 Million ▼ -107.5%
2023 4.76x $1.71 Million $1.71 Million $358.92K ▲ +1021.3%
2021 -0.52x $-66.42K $-71.12K $128.47K ▲ +88.6%
2020 -4.53x $-1.23 Million $-1.95 Million $271.45K ▼ -27195.9%
2019 0.02x $652.00 $652.00 $39.00K ▲ +102.6%
1998 -0.65x $-1.88 Million $-1.93 Million $2.88 Million ▼ -101.5%
1997 -0.32x $-1.67 Million $-1.83 Million $5.13 Million ▲ +0.6%
1996 -0.33x $-1.77 Million $-2.44 Million $5.43 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities